Published in Chemistry on April 14, 2003
A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo. Chem Biol (2006) 1.54
Putting anion-π interactions into perspective. Angew Chem Int Ed Engl (2011) 1.49
Ph2SO/Tf2O: a powerful promotor system in chemoselective glycosylations using thioglycosides. Org Lett (2003) 1.42
Biochemical and genetic studies of the VPg uridylylation reaction catalyzed by the RNA polymerase of poliovirus. J Virol (2003) 1.37
Anion binding involving pi-acidic heteroaromatic rings. Acc Chem Res (2007) 1.33
A modular strategy toward the synthesis of heparin-like oligosaccharides using monomeric building blocks in a sequential glycosylation strategy. J Am Chem Soc (2005) 1.17
Transglycosidase activity of chitotriosidase: improved enzymatic assay for the human macrophage chitinase. J Biol Chem (2003) 1.16
Recognition of base J in duplex DNA by J-binding protein. J Biol Chem (2001) 1.15
The conformation of neurotensin bound to its G protein-coupled receptor. Proc Natl Acad Sci U S A (2003) 1.14
Thioglycuronides: synthesis and application in the assembly of acidic oligosaccharides. Org Lett (2004) 1.11
[Fe(mu-btzmp)2(btzmp)2](ClO4)2: a doubly-bridged 1D spin-transition bistetrazole-based polymer showing thermal hysteresis behaviour. Dalton Trans (2007) 1.10
catena-Poly[[dicyanamido(5,5'-dimethyl-2,2'-bipyridine-kappa2N,N')copper(II)]-mu-dicyanamido-kappa2N1:N5]. Acta Crystallogr C (2002) 1.10
A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole. J Am Chem Soc (2002) 1.09
Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies. J Inherit Metab Dis (2011) 1.07
Mixing of peptides and electrophilic traps gives rise to potent, broad-spectrum proteasome inhibitors. Org Biomol Chem (2007) 1.07
Unique ligand-based oxidative DNA cleavage by zinc(II) complexes of hpyramol and hpyrimol. Chemistry (2007) 1.07
Structure-dependent in vitro cytotoxicity of the isomeric complexes [Ru(L)2Cl2] (L= o-tolylazopyridine and 4-methyl-2-phenylazopyridine) in comparison to [Ru(azpy)2Cl2]. J Biol Inorg Chem (2004) 1.05
Phenanthroline derivatives with improved selectivity as DNA-targeting anticancer or antimicrobial drugs. ChemMedChem (2008) 1.01
Strongly isolated ferromagnetic layers in poly-trans-mu-dichloro- and poly-trans-mu-dibromobis(1-(2-chloroethyl)-tetrazole-N4)copper(II) complexes. Inorg Chem (2002) 1.01
Activity-based profiling reveals reactivity of the murine thymoproteasome-specific subunit beta5t. Chem Biol (2010) 1.01
Development of an activity-based probe and in silico design reveal highly selective inhibitors for diacylglycerol lipase-α in brain. Angew Chem Int Ed Engl (2013) 1.01
Inhibitors of protein: geranylgeranyl transferases. Curr Med Chem (2006) 0.99
Quantification of globotriaosylsphingosine in plasma and urine of fabry patients by stable isotope ultraperformance liquid chromatography-tandem mass spectrometry. Clin Chem (2012) 0.98
Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs. J Inorg Biochem (2002) 0.96
An aromatic anion receptor: anion-pi interactions do exist. Angew Chem Int Ed Engl (2004) 0.96
Bis[bis(2-pyridylcarbonyl)aminato]iron(III) perchlorate acetonitrile disolvate. Acta Crystallogr C (2006) 0.95
Sequential one-pot glycosylations using 1-hydroxyl and 1-thiodonors. Org Lett (2003) 0.94
Synthetic models of the active site of catechol oxidase: mechanistic studies. Chem Soc Rev (2006) 0.94
Synthesis, characterization, in vitro antitumor activity, DNA-binding properties and electronic structure (DFT) of the new complex cis-(Cl,Cl)[RuIICl2(NO+)(terpy)]Cl. Dalton Trans (2005) 0.94
Copper(II)-catalysed aerobic oxidation of primary alcohols to aldehydes. Chem Commun (Camb) (2003) 0.94
Conjugation of nucleosides and oligonucleotides by [3+2] cycloaddition. J Org Chem (2007) 0.93
A Mixed-Valence Tetranuclear Copper Cluster with Localized Valencies. Inorg Chem (1997) 0.93
Application of fluorescence microscopy for investigation of cellular distribution of dinuclear platinum anticancer drugs. J Med Chem (2005) 0.93
From heparin to EP217609: the long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile. Thromb Haemost (2009) 0.93
New antitumour active platinum compounds containing carboxylate ligands in trans geometry: synthesis, crystal structure and biological activity. Dalton Trans (2005) 0.93
Incorporation of non-natural amino acids improves cell permeability and potency of specific inhibitors of proteasome trypsin-like sites. J Med Chem (2013) 0.92
Ruthenium(III) chloride complex with a tridentate bis(arylimino)pyridine ligand: synthesis, spectra, X-ray structure, 9-ethylguanine binding pattern, and in vitro cytotoxicity. Inorg Chem (2008) 0.91
Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells. BMC Cancer (2008) 0.91
Bioorthogonal chemistry: applications in activity-based protein profiling. Acc Chem Res (2011) 0.91
Therapeutic potential of a synthetic peptide inhibitor of nuclear factor of activated T cells as antirestenotic agent. Arterioscler Thromb Vasc Biol (2006) 0.90
High cytotoxicity of cisplatin nanocapsules in ovarian carcinoma cells depends on uptake by caveolae-mediated endocytosis. Clin Cancer Res (2009) 0.90
Discovery of glycine sulfonamides as dual inhibitors of sn-1-diacylglycerol lipase α and α/β-hydrolase domain 6. J Med Chem (2014) 0.89
Structure-toxicity relationships for different types of dinuclear platinum complexes. J Inorg Biochem (2006) 0.89
2-Chloro-pyrimidin-4-amine. Acta Crystallogr Sect E Struct Rep Online (2012) 0.89
The square-planar cytotoxic [Cu(II)(pyrimol)Cl] complex acts as an efficient DNA cleaver without reductant. J Am Chem Soc (2006) 0.89
Trigonal propeller-shaped [Mn(III)3M(II)Na] complexes (M = Mn, Ca): structural and functional models for the dioxygen evolving centre of PSII. Dalton Trans (2011) 0.89
The C-terminal region of Escherichia coli UvrC contributes to the flexibility of the UvrABC nucleotide excision repair system. Nucleic Acids Res (2002) 0.89
Kinetic study of azole-bridged dinuclear platinum(II) complexes reacting with a hairpin-stabilized double-stranded oligonucleotide. J Inorg Biochem (2003) 0.88
Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG. PLoS One (2010) 0.88
ZM241385, DPCPX, MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptor. J Pharmacol Exp Ther (2006) 0.88
Photoaffinity labeling in activity-based protein profiling. Top Curr Chem (2012) 0.88
Functions of base flipping in E. coli nucleotide excision repair. DNA Repair (Amst) (2008) 0.88
Alkylated sugar amino acids: a new entry toward highly functionalized dipeptide isosters. Org Lett (2004) 0.87
N-azidoacetylmannosamine-mediated chemical tagging of gangliosides. J Lipid Res (2007) 0.87
Citations and ethics. Angew Chem Int Ed Engl (2011) 0.87
Random mutagenesis of the human adenosine A2B receptor followed by growth selection in yeast. Identification of constitutively active and gain of function mutations. Mol Pharmacol (2004) 0.86
Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles. J Biol Inorg Chem (2005) 0.86
Surface plasmon resonance evaluation of various aminoglycoside-RNA hairpin interactions reveals low degree of selectivity. Chembiochem (2004) 0.85
New approach for the preparation of efficient DNA cleaving agents: ditopic copper-platinum complexes based on 3-Clip-Phen and cisplatin. J Med Chem (2007) 0.85
Synthesis of oligoribonucleic acid conjugates using a cyclooctyne phosphoramidite. Org Lett (2010) 0.85
A combinatorial approach toward the generation of ambiphilic peptide-based inhibitors of protein:geranylgeranyl transferase-1. J Comb Chem (2005) 0.84
Site-specific interactions of JBP with base and sugar moieties in duplex J-DNA. Evidence for both major and minor groove contacts. J Biol Chem (2002) 0.84
1,3-Dimethyllumazine derivatives from Limnatis nilotica. J Nat Prod (2005) 0.84
Synthesis of sugar nucleotides by application of phosphoramidites. J Org Chem (2008) 0.84
Ruthenium polypyridyl complexes and their modes of interaction with DNA: is there a correlation between these interactions and the antitumor activity of the compounds? J Biol Inorg Chem (2008) 0.84
3-D lanthanide metal-organic frameworks: structure, photoluminescence, and magnetism. Inorg Chem (2009) 0.84
Binding of novel azole-bridged dinuclear platinum(II) anticancer drugs to DNA: insights from hybrid QM/MM molecular dynamics simulations. J Phys Chem B (2006) 0.83
Folic acid-modified mesoporous silica nanoparticles for cellular and nuclear targeted drug delivery. Adv Healthc Mater (2012) 0.83
The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation. J Inorg Biochem (2004) 0.83
A cleavable linker based on the levulinoyl ester for activity-based protein profiling. Angew Chem Int Ed Engl (2010) 0.83
Influence of O6 in mannosylations using benzylidene protected donors: stereoelectronic or conformational effects? J Org Chem (2013) 0.83
Synthesis and elaboration of functionalised carbohydrate-derived spiroketals. Org Biomol Chem (2004) 0.83
Synthesis and biological evaluation of novel turn-modified gramicidin S analogues. Bioorg Med Chem (2003) 0.82
Structure of an anti-Lewis X Fab fragment in complex with its Lewis X antigen. Structure (2004) 0.82
Targeted lysosome disruptive elements for improvement of parenchymal liver cell-specific gene delivery. J Biol Chem (2002) 0.81
Water-soluble platinum(II) complexes of diamine chelating ligands bearing amino-acid type substituents: the effect of the linked amino acid and the diamine chelate ring size on antitumor activity, and interactions with 5'-GMP and DNA. J Inorg Biochem (2004) 0.81
Discovery of a potent and highly β1 specific proteasome inhibitor from a focused library of urea-containing peptide vinyl sulfones and peptide epoxyketones. Org Biomol Chem (2011) 0.81
Controlled copper-mediated chlorination of phenol rings under mild conditions. Inorg Chem (2007) 0.81
Poly(ethylene glycol)-based stable isotope labeling reagents for the quantitative analysis of low molecular weight metabolites by LC-MS. Anal Chem (2008) 0.81
Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part II. Cellular processing in A2780 cisplatin-resistant human ovarian carcinoma cells: new insights into the mechanism of resistance. J Biol Inorg Chem (2004) 0.81
Effect of bulky lesions on DNA: solution structure of a DNA duplex containing a cholesterol adduct. J Biol Chem (2004) 0.81
Platinated copper(3-clip-phen) complexes as effective DNA-cleaving and cytotoxic agents. Chemistry (2008) 0.81
Cytotoxic activity and cellular processing in human ovarian carcinoma cell lines of a new platinum(II) compound containing a fluorescent substituted propylene diamine ligand. Biochem Pharmacol (2009) 0.81
(Aminoethanol)dichloroplatinum(II) complexes: influence of the hydroxyethyl moiety on 5'-GMP and DNA binding, intramolecular stability, the partition coefficient and anticancer activity. J Inorg Biochem (2002) 0.81
Proton NMR spectroscopy and magnetic properties of a solution-stable dicopper(II) complex bearing a single mu-hydroxo bridge. Inorg Chem (2005) 0.81